Home > Results > JumpStart News > Theravasc Inc. Wins $500,000 Investment Commitment to Try Vascular Disease Drug

Theravasc Inc. Wins $500,000 Investment Commitment to Try Vascular Disease Drug

Tuesday, January 05, 2010

Excerpt of story provided by MedCity News
Written by Mary Vanac

Theravasc Inc., a Cleveland company that is reformulating an approved drug to treat vascular diseases, has received investment commitments of $500,000 to do its initial clinical study.

JumpStart Inc., the venture development organization in Cleveland, and Portal Capital LLC, the early stage life sciences investment firm in Beachwood, each committed $250,000.

In June, Theravasc received a $100,000 grant from the Innovation Fund at the Lorain County Community College Foundation...

Read the complete article.

JumpStart cannot be responsible for broken links on third party sites.

probe